Ensign Peak Advisors’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.53M | Buy |
|
|||||
|
2025
Q1 | $211K | Sell |
|
|||||
|
2024
Q4 | $7.44M | Buy |
|
|||||
|
2024
Q3 | $11.2M | Hold |
|
|||||
|
2024
Q2 | $11M | Sell |
|
|||||
|
2024
Q1 | $17.4M | Buy |
|
|||||
|
2023
Q4 | $6.8M | Hold |
|
|||||
|
2023
Q3 | $4.58M | Hold |
|
|||||
|
2023
Q2 | $5.75M | Buy |
|
|||||
|
2023
Q1 | $2.61M | Buy |
|
|||||
|
2022
Q4 | $464K | Sell |
|
|||||
|
2022
Q3 | $562K | Buy |
|
|||||
|
2022
Q2 | $275K | Hold |
|
|||||
|
2022
Q1 | $386K | Hold |
|
|||||
|
2021
Q4 | $476K | Hold |
|
|||||
|
2021
Q3 | $650K | Hold |
|
|||||
|
2021
Q2 | $842K | Hold |
|
|||||
|
2021
Q1 | $621K | Hold |
|
|||||
|
2020
Q4 | $840K | Hold |
|
|||||
|
2020
Q3 | $808K | Buy |
|